Staging and reporting of urothelial carcinoma of the urinary bladder. - Wikidata - wikimedia - TriplyDB

Staging and reporting of urothelial carcinoma of the urinary bladder.

Staging and reporting of urothelial carcinoma of the urinary bladder.

http://www.wikidata.org/entity/Q34984796

about

New and contemporary markers of prognosis in nonmuscle invasive urothelial cancer Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion.Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.An ancillary method in urine cytology: Nucleolar/nuclear volume ratio for discrimination between benign and malignant urothelial cells.Lack of evidence for increased level of circulating urothelial cells in the peripheral blood after transurethral resection of bladder tumors.Expression of GLUT1 is associated with increasing grade of malignancy in non-invasive and invasive urothelial carcinomas of the bladder.Down-staging (<pT2) of urothelial cancer at cystectomy after the diagnosis of detrusor muscle invasion (pT2) at diagnostic transurethral resection (TUR): is prediction possible?CCR7 as a predictive biomarker associated with computed tomography for the diagnosis of lymph node metastasis in bladder carcinoma Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy.Nanotechnology and cancer: improving real-time monitoring and staging of bladder cancer with multimodal mesoporous silica nanoparticles.UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy.Clinical Behavior of Bladder Urothelial Carcinoma in Young Patients: A Single Center Experience.Expression of extracellular matrix metalloproteinase inducer and fascin in urinary bladder cancer: Correlation with clinicopathological characteristics.Challenges in the pathology of non-muscle-invasive bladder cancer: a dialogue between the urologic surgeon and the pathologist.HER2 protein overexpression and gene amplification in upper urinary tract urothelial carcinoma-an analysis of 171 patients Analysis of the Distribution and Temporal Trends of Grade and Stage in Urothelial Bladder Cancer in Northern New England from 1994 to 2004.A contemporary update on pathology reporting for urinary bladder cancer.High-risk non-muscle-invasive bladder cancer: update for a better identification and treatment.Efficacy, pharmacokinetic and pharmacodynamic evaluation of apaziquone in the treatment of non-muscle invasive bladder cancer.Maintenance monotherapy with Gemcitabine following cisplatin-based primary combination chemotherapy in surgically treated advanced urothelial carcinoma: A matched-pair single institution analysis.Three-tiered nodal classification system for bladder cancer: a new proposal.Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: a multi-institutional analysis of 795 cases.Impact of body mass index on the oncological outcomes of patients treated with radical cystectomy for muscle-invasive bladder cancer.The determination of serum and urinary endocan concentrations in patients with bladder cancer.A case of urinary bladder urothelial carcinoma with squamous, glandular, and plasmacytoid differentiation.Morphological changes in peri-prostatic sympathetic ganglion cells in aging males.How much do you know about benign, preneoplastic, non-invasive and invasive neoplastic lesions of the urinary bladder classified according to the 2004 WHO scheme?Detection of hyaluronidase RNA and activity in urine of schistosomal and non-schistosomal bladder cancer.Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma.Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.Immunohistochemical analysis of the role and relationship between Notch-1 and Oct-4 expression in urinary bladder carcinoma.Spatial and temporal profile of cisplatin delivery by ultrasound-assisted intravesical chemotherapy in a bladder cancer model.Molecular factors regulating E-cadherin expression in urothelial bladder cancer and their correlations with the clinicopathological features.Histopathology: ditch the slides, because digital and 3D are on show.The Binding Site Barrier Elicited by Tumor-Associated Fibroblasts Interferes Disposition of Nanoparticles in Stroma-Vessel Type Tumors.Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP).An analysis of the polymorphisms of the GLUT1 gene in urothelial cell carcinomas of the bladder and its correlation with p53, Ki67 and GLUT1 expressions.Meeting report: Urinary Pathology; sixth Research Triangle Park Rodent Pathology Course.Pathology of upper tract urothelial carcinoma with emphasis on staging.Surveillance guidelines based on recurrence patterns for upper tract urothelial carcinoma.

P2860

Q26798006-247D84DD-A046-43E7-AB0E-6EE6806CD5B9 Q33772333-87FDF583-C0DF-4E6E-BEA0-746D9521632A Q34826155-F7F03E60-DB64-43A4-B44B-BD3856DEEB42 Q35955528-6D127CE2-E52B-41D5-A523-5A9FCD5B65D5 Q35981404-AC2883B3-5F99-4885-B1B0-0B9F5E21850B Q36121595-EE23DEA5-416A-4A35-AE32-3385AF10BEFD Q36170392-51A7B665-4C68-4D5F-9DA8-E8EFB6A4FC5C Q36502834-A571765F-A47E-4664-9A05-A9324504FABC Q36598752-C8EC0675-69C3-4026-B5A5-76A60F7FBDF5 Q36840575-0AE87CC3-0E12-47D8-803E-7661962F4730 Q36956211-70CF0C04-5094-4883-ADC6-AF092A45F994 Q37176840-652E30E2-5F1E-4F58-AECE-17FDF6687629 Q37562379-550911A5-F9FC-49DE-9A08-DFBF052DFEE4 Q37577902-7FF08A82-7249-4D99-86E7-190F9CCE4DBA Q37587395-80B12FD2-9986-4A58-8C23-4CE534E7B53A Q37664017-F7A5277B-93BA-4034-B817-CA309844410F Q38051444-80714AD6-A479-4D1F-9755-76A4FE21B490 Q38052445-A9081EFB-A970-4C4D-A808-62DBF8479453 Q38668376-28E98F70-E8D8-45DD-A143-3B6D4A365A0E Q38881827-0AF32229-88B2-4102-AAF1-86FFA8D62F13 Q39040340-54473FED-74C6-4F36-8E29-4686ECE94513 Q39953451-801C9858-BD8C-43CC-B6D0-8359FDDEB202 Q40714046-06C2ABB6-9909-4B1F-B5B9-47468A89F69E Q40839414-220075AE-C448-4391-9D89-F3A9F9A23B38 Q41042829-B7B3B46C-F02A-4C25-97AE-A06E2E89B2DC Q42120571-37F3E812-6301-46FB-9A53-DD72239AB6F6 Q42745710-51FCF75A-7660-49F2-9F45-8D3C277C2135 Q44204551-350BE89E-C77D-498D-B1E2-A417F77C3930 Q45819570-5AD74032-8108-4DE9-AEC2-C1BE222041D2 Q46103336-EA637B51-B49C-4673-9F47-730919AEC57F Q46619102-819DDC58-47AC-4188-A897-50F473C9B468 Q47126818-AC20B50F-3EB8-46DF-8FC9-C8DA8A06D671 Q47951789-75F992C0-80AC-4E5F-B0E4-5BF2C9076E17 Q48501024-BE1D2700-A112-4107-8CEA-1A5835D19BB5 Q50579985-A2054F57-DD90-44D5-B432-13DD4971D37B Q53158342-C42F17E3-CF7B-40DC-B1E5-57042776BAD2 Q53186470-76807BF6-95AA-49C9-B535-038E909B435C Q53330942-5C58E1E8-B173-4EFA-8404-A411EEF1BD90 Q53649386-40B4F371-1993-4788-8F05-4C2D7F8AB1F3 Q53821066-29AB98AF-6D04-4136-B940-5FD66445AD8F

P2860

Staging and reporting of urothelial carcinoma of the urinary bladder.

http://www.wikidata.org/entity/Q34984796

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Staging and reporting of urothelial carcinoma of the urinary bladder.

@ast

Staging and reporting of urothelial carcinoma of the urinary bladder.

@en

Staging and reporting of urothelial carcinoma of the urinary bladder.

@nl

type

label

Staging and reporting of urothelial carcinoma of the urinary bladder.

@ast

Staging and reporting of urothelial carcinoma of the urinary bladder.

@en

Staging and reporting of urothelial carcinoma of the urinary bladder.

@nl

prefLabel

Staging and reporting of urothelial carcinoma of the urinary bladder.

@ast

Staging and reporting of urothelial carcinoma of the urinary bladder.

@en

Staging and reporting of urothelial carcinoma of the urinary bladder.

@nl

P1433

Q34984796-8C1DBDFD-9CF5-404C-9ADF-BCC9AF7A07EB

P1476

Q34984796-6E94C0C8-0F14-40AB-85DD-8BE1D66D90A7

P2093

Q34984796-76CC9E26-EEEB-4E5A-B1B5-7B2BD2BAF244

Q34984796-BC76B62B-3C46-48DF-871D-8CBB03119FDC

Q34984796-E9F67702-21A3-4D4B-BCC2-BFE03D51CBC7

P2860

Q34984796-122250EC-F6C7-4344-B4BC-E147194B2B0F

Q34984796-1AD98310-78F2-48BB-A31B-7FFCD0612FA5

Q34984796-2624742B-A129-4D16-B4E3-C8B8C894F1CA

Q34984796-2A002DA6-4AAB-46F7-B38A-56B542FF5F43

Q34984796-2EC47C4C-92D9-42A9-B662-86FAAF40FA81

Q34984796-315473F0-92EA-42F9-8F05-5345EB8E67C5

Q34984796-358C750D-9455-408D-835F-7BDB68AD1BF5

Q34984796-362125DB-D4C3-4B1E-80FD-CBFB865A6360

Q34984796-3A3422C9-862D-4017-A8E4-F1E58DB492F8

Q34984796-3F9A5E7C-4A32-4A4A-898C-8063B5B582E6

P2888

Q34984796-7859153A-9570-4A76-B938-A431297AF090

P304

Q34984796-B6B5737D-11FE-4F40-820C-77BB82682CF8

P31

Q34984796-0365CAFF-1C3B-4E54-A914-3A2F528226A2

P356

Q34984796-16F66397-3D5F-4D08-99BB-3190D1F306A6

P478

Q34984796-E9996C56-9361-4463-9989-CF5032429723

P50

Q34984796-B13F8C9E-9188-4E1F-876B-C42986D2528D

P577

Q34984796-7D022F09-9157-49AC-9E88-57FCE4B6CF0F

P5875

Q34984796-92814D80-B4D1-4341-9819-BB9F3A35EEF3

P6179

Q34984796-7D093F83-C2B4-4697-8C2E-F71B42F3509E

P698

Q34984796-B1A105E1-B02A-4D7F-A410-33426B06CEE1

P356

MODPATHOL.2009.1

P1433

Modern Pathology

P1476

Staging and reporting of urothelial carcinoma of the urinary bladder.

@en

P2093

Antonio Lopez-Beltran

http://www.w3.org/2001/XMLSchema#string

Darrell D Davidson

http://www.w3.org/2001/XMLSchema#string

Liang Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2008

Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma.

Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder.

Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.

Molecular evidence supporting field effect in urothelial carcinogenesis.

Holmium laser enucleation of the prostate: a size-independent new "gold standard".

Bladder. Risk and prognostic factors--a pathologist's perspective.

Diagnosis and grading of bladder cancer and associated lesions.

Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer.

Histologic grading of noninvasive papillary urothelial neoplasms.

P2888

modpathol.2009.1

P304

S70-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2009.1

http://www.w3.org/2001/XMLSchema#string

P478

22 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P50

Rodolfo Montironi

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26265249

http://www.w3.org/2001/XMLSchema#string

P6179

1022811996

http://www.w3.org/2001/XMLSchema#string

P698

19494855

http://www.w3.org/2001/XMLSchema#string